Actinium Pharmaceuticals, Inc. (ATNM) vs Cassava Sciences, Inc. (FLNA)
Actinium Pharmaceuticals, Inc. and Cassava Sciences, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Cassava Sciences, Inc. are of similar size ($37.8M and $37.4M). Cassava Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.3×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against 277.6%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Actinium Pharmaceuticals, Inc. leads on 11 and Cassava Sciences, Inc. on 3.
Valuation
Profitability
| Metric | ATNM | FLNA | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 0.00% | 65.16% |
| Operating margin | 27.20% | 0.00% | 0.00% |
| Net margin | 32.18% | 0.00% | 0.00% |
| Free cash flow margin | (66.16%) | 0.00% | 0.00% |
| Return on equity | 45.86% | (55.78%) | (57.72%) |
| Return on assets | 21.92% | (35.34%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack